Welcome to our dedicated page for ACACIA RESEARCH SEC filings (Ticker: ACTG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ACACIA RESEARCH's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ACACIA RESEARCH's regulatory disclosures and financial reporting.
Molinelli Gavin reported acquisition or exercise transactions in this Form 4 filing.
ACACIA RESEARCH CORP director Gavin Molinelli received 6,438 shares of common stock on June 30, 2026, as a grant in lieu of cash for Q2 2026 director fees. The grant was priced at $4.66 per share and increased his direct holdings to 205,966 shares of common stock. This was a compensation-related share award rather than an open-market purchase or sale.
Sundar Ajay reported acquisition or exercise transactions in this Form 4 filing.
ACACIA RESEARCH CORP insider Ajay Sundar reported receiving a grant of 4,175 shares of Common Stock at $4.79 per share as Q2 2026 director fees paid in stock instead of cash. Following this award, he directly holds 107,605 shares. As of June 23, 2026, he ceased to be a director of the company.
Molinelli Gavin reported acquisition or exercise transactions in this Form 4 filing.
Acacia Research Corp director Gavin Molinelli received a new equity award. He was granted 25,052 shares of common stock as restricted stock on June 23, 2026, at no purchase price, as part of the company’s annual equity awards to non-employee directors under the 2024 Stock Incentive Plan.
The filing states that 100% of this restricted stock will vest on the first anniversary of the grant date. After this award, Molinelli directly holds 199,528 shares of Acacia Research common stock, reflecting ongoing stock-based compensation rather than an open-market purchase.
Kohlberg Isaac T. reported acquisition or exercise transactions in this Form 4 filing.
Acacia Research Corp director Isaac T. Kohlberg received a grant of 25,052 shares of ACTG common stock as restricted stock. The award was granted on June 23, 2026 as part of the company’s annual equity awards to non-employee directors under the 2024 Stock Incentive Plan.
All of the restricted stock will vest on the first anniversary of the grant date, meaning the shares become fully owned at that time if conditions are met. Following this grant, Kohlberg directly holds a total of 110,498 shares of Acacia Research common stock as reported in the filing.
OCONNELL MAUREEN reported acquisition or exercise transactions in this Form 4 filing.
Acacia Research director Maureen O’Connell reported an equity grant of company stock. On June 23, 2026 she received 25,052 shares of Acacia Research common stock as restricted stock, awarded as part of the company’s annual equity grants to non-employee directors under the 2024 Stock Incentive Plan.
The restricted stock will vest 100% on the first anniversary of the grant date. Following this award, O’Connell directly holds 297,655 shares of Acacia Research common stock. The grant carries no cash purchase price and reflects compensation rather than an open-market trade.
FELMAN MICHELLE reported acquisition or exercise transactions in this Form 4 filing.
ACACIA RESEARCH CORP director Michelle Felman reported an equity grant of company stock. On June 23, 2026, she received 25,052 shares of ACTG common stock at no cash cost as a grant or award, increasing her direct holdings to 57,224 shares.
The award is restricted stock granted as part of the company’s annual equity program for non-employee directors under the 2024 Acacia Research Corporation Stock Incentive Plan. According to the terms, 100% of the restricted stock will vest on the first anniversary of the grant date.
Acacia Research Corporation reported the results of its 2026 Annual Meeting of Stockholders. As of the April 28, 2026 record date, 96,589,132 common shares were issued, outstanding and entitled to vote, and 86,674,540 shares were represented at the meeting, constituting a quorum.
Stockholders elected seven directors to serve until the 2027 Annual Meeting or until their successors are duly elected and qualified. They also ratified the appointment of Grant Thornton LLP as independent registered public accounting firm for the year ending December 31, 2026, and approved, on a non-binding advisory basis, the compensation of the named executive officers.
Acacia Research Corp General Counsel Jason W. Soncini reported equity compensation activity involving ACTG common stock. On June 5, 2026, he acquired 93,049 shares at $0.00 per share as a grant or award, increasing his direct holdings at that time to 284,600 shares.
On June 8, 2026, 48,985 shares were disposed of at $4.62 per share to satisfy tax withholding obligations related to equity vesting, a non‑market tax-withholding disposition rather than an open-market sale. After these transactions, he directly owned 235,615 ACTG shares.
Footnotes explain that these awards trace back to performance-based restricted stock units granted on June 7, 2023, tied to the company’s compound annual growth rate of adjusted book value per share. On June 5, 2026, the Compensation Committee certified the number of units earned based on achievement of this performance goal, with 121,550 restricted shares vesting on June 7, 2026.
Acacia Research Chief Administrative Officer Robert Rasamny reported equity compensation activity involving ACTG Common Stock. On June 5, 2026, he acquired 60,285 shares at $0.00 per share as a grant or award tied to performance-based restricted stock units originally granted in June 2023. On June 8, 2026, 28,390 shares were disposed of at $4.62 per share to satisfy tax withholding obligations related to the vesting of 78,750 restricted shares, leaving him with 73,976 directly held shares.
Acacia Research Corp Chief Executive Officer equity award and tax withholding are reported in this Form 4. On June 5, 2026, Martin D. McNulty Jr. acquired 539,160 shares of ACTG common stock at $0.00 per share as a grant or award, increasing his direct holdings to 705,563 shares.
The award relates to performance-based restricted stock units granted on June 7, 2023, tied to the company’s compound annual growth rate of adjusted book value per share. On June 8, 2026, 287,133 shares were disposed of at $4.62 per share solely to satisfy tax withholding obligations for the vesting of 568,303 shares of restricted stock on June 7, 2026. After this tax-withholding disposition, the CEO directly holds 418,430 shares of ACTG common stock.